(Q38432288)

English

Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer

scientific article published on 12 April 2014

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Armando Santoro

object named as

A Santoro

15

0 references

Roberto Labianca

object named as

R Labianca

4

0 references

Alfredo Falcone

object named as

A Falcone

5

0 references

author name string

E Bajetta

1

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

I Floriani

2

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

M Di Bartolomeo

3

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

F Di Costanzo

6

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

G Comella

7

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

D Amadori

8

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

C Pinto

9

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

C Carlomagno

10

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

D Nitti

11

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

B Daniele

12

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

E Mini

13

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

D Poli

14

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

S Mosconi

16

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

R Casaretti

17

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

C Boni

18

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

G Pinotti

19

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

P Bidoli

20

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

L Landi

21

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

G Rosati

22

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

A Ravaioli

23

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

M Cantore

24

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

F Di Fabio

25

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

E Aitini

26

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

A Marchet

27

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

ITACA-S (Intergroup Trial of Adjuvant Chemotherapy in Adenocarcinoma of the Stomach Trial) Study Group

28

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

publication date

12 April 2014

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Annals of Oncology

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

25

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

1373-1378

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU146

21 January 2018

Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU146

21 January 2018

Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU146

21 January 2018

Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU146

21 January 2018

Feasibility of sequential therapy with FOLFIRI followed by docetaxel/cisplatin in patients with radically resected gastric adenocarcinoma. A randomized phase III trial

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU146

21 January 2018

Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU146

21 January 2018

Adjuvant treatment of high-risk, radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU146

21 January 2018

Adjuvant chemotherapy in completely resected gastric cancer: a randomized phase III trial conducted by GOIRC.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU146

21 January 2018

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU146

21 January 2018

A phase II study of preoperative chemotherapy with S-1 plus cisplatin followed by D2/D3 gastrectomy for clinically serosa-positive gastric cancer (JACCRO GC-01 study).

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU146

21 January 2018

Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU146

21 January 2018

Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU146

21 January 2018

Updated analysis of SWOG-directed intergroup study 0116: a phase III trial of adjuvant radiochemotherapy versus observation after curative gastric cancer resection

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU146

21 January 2018

Phase III trial comparing capecitabine plus cisplatin versus capecitabine plus cisplatin with concurrent capecitabine radiotherapy in completely resected gastric cancer with D2 lymph node dissection: the ARTIST trial

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDU146

21 January 2018

Identifiers

10.1093/ANNONC/MDU146

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38432288&oldid=1759608474"